Protalix BioTherapeutics Future Growth
Future criteria checks 5/6
Protalix BioTherapeutics is forecast to grow earnings and revenue by 96.5% and 34.7% per annum respectively while EPS is expected to grow by 90% per annum.
Key information
96.5%
Earnings growth rate
90.0%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | 34.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 127 | 70 | N/A | N/A | 1 |
12/31/2024 | 74 | 18 | N/A | N/A | 1 |
12/31/2023 | 65 | 8 | -2 | -1 | N/A |
9/30/2023 | 64 | 11 | -9 | -8 | N/A |
6/30/2023 | 67 | 9 | -11 | -10 | N/A |
3/31/2023 | 41 | -16 | -23 | -22 | N/A |
12/31/2022 | 48 | -15 | -26 | -25 | N/A |
9/30/2022 | 48 | -18 | -28 | -27 | N/A |
6/30/2022 | 45 | -18 | -21 | -20 | N/A |
3/31/2022 | 43 | -24 | -8 | -6 | N/A |
12/31/2021 | 38 | -28 | -12 | -10 | N/A |
9/30/2021 | 49 | -21 | -14 | -13 | N/A |
6/30/2021 | 48 | -21 | -16 | -14 | N/A |
3/31/2021 | 53 | -14 | -30 | -29 | N/A |
12/31/2020 | 63 | -7 | -27 | -26 | N/A |
9/30/2020 | 61 | -7 | -23 | -22 | N/A |
6/30/2020 | 65 | -6 | -23 | -22 | N/A |
3/31/2020 | 66 | -9 | -20 | -19 | N/A |
12/31/2019 | 55 | -18 | -20 | -19 | N/A |
9/30/2019 | 47 | -24 | -20 | -20 | N/A |
6/30/2019 | 45 | -26 | -3 | -3 | N/A |
3/31/2019 | 38 | -26 | -6 | -6 | N/A |
12/31/2018 | 34 | -26 | -8 | -8 | N/A |
9/30/2018 | 28 | -34 | 13 | 14 | N/A |
6/30/2018 | 23 | -40 | -11 | -10 | N/A |
3/31/2018 | 25 | -32 | -12 | -11 | N/A |
12/31/2017 | 21 | -83 | -11 | -10 | N/A |
9/30/2017 | 19 | -73 | N/A | -35 | N/A |
6/30/2017 | 16 | -69 | N/A | -28 | N/A |
3/31/2017 | 11 | -80 | N/A | -31 | N/A |
12/31/2016 | 9 | -29 | N/A | -32 | N/A |
9/30/2016 | 7 | -35 | N/A | -29 | N/A |
6/30/2016 | 4 | -34 | N/A | -34 | N/A |
3/31/2016 | 3 | -29 | N/A | -27 | N/A |
12/31/2015 | 4 | -27 | N/A | -24 | N/A |
9/30/2015 | -6 | -31 | N/A | -25 | N/A |
6/30/2015 | -4 | -33 | N/A | -26 | N/A |
3/31/2015 | -2 | -32 | N/A | -27 | N/A |
12/31/2014 | 4 | -33 | N/A | -29 | N/A |
9/30/2014 | 15 | -32 | N/A | -29 | N/A |
6/30/2014 | 15 | -30 | N/A | -28 | N/A |
3/31/2014 | 15 | -31 | N/A | -29 | N/A |
12/31/2013 | N/A | -35 | N/A | -31 | N/A |
9/30/2013 | 10 | -27 | N/A | -24 | N/A |
6/30/2013 | 12 | -27 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PLX's forecast earnings growth (96.5% per year) is above the savings rate (2.4%).
Earnings vs Market: PLX's earnings (96.5% per year) are forecast to grow faster than the US market (14.1% per year).
High Growth Earnings: PLX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PLX's revenue (34.7% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: PLX's revenue (34.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PLX's Return on Equity is forecast to be high in 3 years time